The Poly(I)·Poly(C) Lyophilised Powder, 265 mg (27473201) is a double-stranded polyribonucleotide reagent used for in vitro interferon stimulation studies. This 265 mg Poly(I)·Poly(C) format is supplied as a lyophilised powder and is used to mimic viral infection in cell-based research workflows.
Key Features
- Poly(I)·Poly(C) reagent, supplied as a double-stranded polyribonucleotide for molecular biology research use
- 265 mg pack size, matching the POLY(I)POLY(C), 265MG variant code
- Lyophilised powder format, suitable for laboratories preparing reagent solutions according to their own protocols
- In vitro interferon stimulation use, specified for stimulation of interferon production in vitro
- Viral infection mimic, designed to activate various cell types by mimicking a viral infection
- Immune cell activation scope, including B lymphocytes, macrophages, and dendritic cells
Benefits
- Supports research workflows investigating interferon induction and immune cell stimulation.
- Provides a defined 265 mg lyophilised format for controlled preparation in the laboratory.
- Helps researchers model viral infection response pathways in vitro.
- Can be used in cell-based studies involving B lymphocytes, macrophages, or dendritic cells.
Why Choose the Poly(I)·Poly(C) Lyophilised Powder, 265 mg (27473201)?
The Poly(I)·Poly(C) Lyophilised Powder, 265 mg (27473201) is a practical choice for laboratories studying in vitro interferon production and immune cell response to viral infection mimicry. John Morris Group supplies molecular biology reagents to Australian laboratories that need dependable consumables for genomics, immunology, and cell biology workflows.
